These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20631015)

  • 61. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
    Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Association of aldosterone synthase gene -344T/C polymorphism with plasma aldosterone and angiotensin II concentration in hypertensive patients].
    Hu BC; Chu SL; Wang JG; Wang ZH; Wang GL; Gao PJ; Zhu DL
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1144-7. PubMed ID: 16796847
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients.
    Bai X; Xu C; Wen D; Chen Y; Li H; Wang X; Zhou L; Huang M; Jin J
    Psychopharmacology (Berl); 2018 Sep; 235(9):2665-2673. PubMed ID: 29984389
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population.
    Rooki H; Haerian MS; Azimzadeh P; Mirhafez R; Ebrahimi M; Ferns G; Ghayour-Mobarhan M; Zali MR
    Mol Biol Rep; 2014 May; 41(5):3127-33. PubMed ID: 24464185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism.
    Montori VM; Schwartz GL; Chapman AB; Boerwinkle E; Turner ST
    Mayo Clin Proc; 2001 Sep; 76(9):877-82. PubMed ID: 11560297
    [TBL] [Abstract][Full Text] [Related]  

  • 69. alpha-Adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study.
    Sugimoto K; Hozawa A; Katsuya T; Matsubara M; Ohkubo T; Tsuji I; Motone M; Higaki J; Hisamachi S; Imai Y; Ogihara T
    J Hypertens; 2002 Sep; 20(9):1779-84. PubMed ID: 12195119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension.
    Rayner BL; Owen EP; King JA; Soule SG; Vreede H; Opie LH; Marais D; Davidson JS
    J Hypertens; 2003 May; 21(5):921-6. PubMed ID: 12714866
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serial renin-angiotensin studies in spontaneously hypertensive and Wistar-Kyoto normotensive rats. Transition from normal- to high-renin status during the established phase of spontaneous hypertension.
    Bagby SP; McDonald WJ; Mass RD
    Hypertension; 1979; 1(4):347-54. PubMed ID: 396238
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients.
    Hansen L; Ekstrøm CT; Tabanera Y Palacios R; Anant M; Wassermann K; Reinhardt RR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3446-50. PubMed ID: 16822823
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evolutionary context for the association of γ-globin, serum uric acid, and hypertension in African Americans.
    Shriner D; Kumkhaek C; Doumatey AP; Chen G; Bentley AR; Charles BA; Zhou J; Adeyemo A; Rodgers GP; Rotimi CN
    BMC Med Genet; 2015 Nov; 16():103. PubMed ID: 26686224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of the renin gene polymorphism, three angiotensinogen gene polymorphisms and the haplotypes with essential hypertension in the Mongolian population.
    Ying CQ; Wang YH; Wu ZL; Fang MW; Wang J; Li YS; Zhang YH; Qiu CC
    Clin Exp Hypertens; 2010; 32(5):293-300. PubMed ID: 20662730
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication.
    Ylihärsilä H; Eriksson JG; Forsén T; Laakso M; Uusitupa M; Osmond C; Barker DJ
    J Hypertens; 2004 Jul; 22(7):1283-7. PubMed ID: 15201543
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites.
    Zhu H; Sagnella GA; Dong Y; Miller MA; Onipinla A; Markandu ND; MacGregor GA
    J Hypertens; 2003 Jan; 21(1):87-95. PubMed ID: 12544440
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between peroxisome proliferator-activated receptor γ gene polymorphism and susceptibility to northwest dryness syndrome.
    Wang Y; Wang X; Zeng B; Guo F; He Y; He J; Liu B
    J Tradit Chin Med; 2017 Apr; 37(2):201-6. PubMed ID: 29960292
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H; Palmgren E; Widgren B; Aurell M
    Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.